Arteriovenous (Av) Fistula Needle Market Size, Share, Growth, and Industry Analysis, By Type (15 Gauge, 16 Gauge, 17 Gauge, Other), By Application (Dialysis Center, Home Dialysis, Other) and Regional Forecast to 2032

ARTERIOVENOUS (AV) FISTULA NEEDLE MARKET REPORT OVERVIEW

The global arteriovenous (Av) fistula needle market size was USD 186 million in 2022 and the market is projected to touch USD 269 million by 2032, exhibiting a CAGR of 3.7% during the forecast period.

An arteriovenous fistula (Av) is a medical device used to puncture an arteriovenous fistula during hemodialysis. It is placed on the patient's arm and allows the patient's blood vessels to be connected to the hemodialysis machine. This enables efficient removal of waste products and excess fluid from the patient's blood during dialysis.

The future outlook for the arteriovenous (Av) fistula needle market is promising. Increasing prevalence of end-stage renal disease and increasing number of patients requiring hemodialysis are the major drivers for market growth. In addition, technological advancements leading to the development of more efficient and user-friendly AV fistula needles are expected to fuel market growth.

COVID-19 Impact: Market Growth Increased by Pandemic due to Growing Demand

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

COVID-19 has affected the economy in three main ways directly affecting the production and demand of medicines, causing disruptions in distribution channels, and through economic effects on companies and financial markets. Due to nationwide lockdowns, several countries like China, India, Saudi Arabia, UAE, Egypt and others are facing problems in transporting drugs from one place to another. However, the COVID-19 pandemic has had a positive impact on the global safety pin market. The COVID-19 pandemic has affected every country in the world and the US states are taking various measures to prevent its spread. For example, in May 2020, the Centers for Disease Control and Prevention (CDC) began working on the Whole-of-Government and All-America strategy to strengthen case detection, contact tracing and testing capabilities in all US states and reopen.

LATEST TRENDS

"Increasing Adoption Of Minimally Invasive Procedures Will Drive Market Growth"

Some of the emerging trends in the global arteriovenous (AV) fistula needle market include increasing adoption of minimally invasive procedures, advances in needle design and technology, increasing prevalence of chronic kidney disease (CKD), and increasing demand for hemodialysis. In addition, we are transitioning to the use of high-quality AV fistula needles, which offer better safety and fewer complications. Innovations such as safety needles and disposable needles are also gaining traction. In addition, manufacturers are focusing on collaborations and partnerships to develop innovative products and expand their market presence, which will further fuel the arteriovenous (Av) fistula needle market growth.

ARTERIOVENOUS (AV) FISTULA NEEDLE MARKET SEGMENTATION

• By Type

Based on type the global market can be categorized into 15 Gauge, 16 Gauge, 17 Gauge, Other.

15 gauge: These variations are related to needle diameter, with a smaller gauge indicating a larger needle size. This gauge having diameter of 15.

Each meter is sized to meet specific medical requirements, such as blood flow and patient comfort. Additionally, other market options are available but their specific features are not mentioned. The selection of Av Fistula Needle sizes allows healthcare professionals to select the most appropriate needle for vascular procedures based on individual patient needs.

• By Application

Based on application the global market can be categorized into Dialysis Center, Home Dialysis, Other.

Dialysis Center: The venovenous (AV) needle market finds widespread use in dialysis centers where it is used to access blood vessels during hemodialysis procedures.

Home Dialysis: In addition, AV fistula needles are also used in home dialysis settings, allowing patients to undergo dialysis treatment in the comfort of their own home.

In addition to these primary markets, AV fistula needles are also used in other healthcare settings such as hospitals, clinics and ambulatory surgery centers. The versatile use of AV fistula needles in this market ensures adequate and efficient blood access during dialysis procedures for patients with renal failure or CKD.

DRIVING FACTORS

"Increasing Prevalence Of Chronic Kidney Diseases Boost The Market Growth"

The increasing prevalence of CKD together with the increasing number of patients undergoing regular hemodialysis has greatly increased the demand for safe fistula needles. The growth of the market has been fueled by the global increase in kidney diseases, which is mainly due to sedentary lifestyle, aging population and prevalence of diabetes and hypertension. Effective government policies such as awareness about proper use of needles, safety measures campaigns and so on are expected to drive the global safety needles market. For example, in April 2022, the American Medical Association (AMA) is calling on states to adopt the new Maine Needle and Syringe Exchange Policy to change restrictive laws and regulations on the sale and possession of needles and syringes to maximize the availability of sterile needles. and syringes. needles.

"Technological Advances And Product Innovations Fuel The Market Growth"

Manufacturers actively invest in research and development to implement advanced safety features, ergonomic design and user-friendly features in safety fistula needles. Such product innovations not only accelerated time to market, but also promoted safer and more effective healthcare practices.

RESTRAINING FACTORS

"Product Recalls By Authorities May Impede Market Growth"

The safety needle market may face growth constraints due to the prevalence of needlestick injuries, contamination and delays in treatment. Patient fear of infections and pain from needles has restrained the market and expansion of safety needles.

ARTERIOVENOUS (AV) FISTULA NEEDLE MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America Dominating the Market due to Growing Demand For AVF Procedures"

North America accounted for the largest arteriovenous (Av) fistula needle market share of revenue in 2022. North America has significant kidney disease and AVF devices play a key role in providing vascular access for hemodialysis. Growing demand for AVF procedures and emphasis on improving patient outcomes is driving regional market growth. In North America, the fistula safety needle market has seen steady growth due to the rise in kidney disease and the introduction of advanced dialysis techniques. The region has a well-developed healthcare infrastructure and high patient awareness, which is contributing to the growth of the market.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Innovation and Market Expansion"

The arteriovenous (Av) fistula needle market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.

LIST OF TOP ARTERIOVENOUS (AV) FISTULA NEEDLE COMPANIES

• Nipro (Japan)
• Fresenius (Germany)
• B. Braun (Germany)
• Kawasumi Lab (Japan)
• Asahi Kasei (Japan)
• JMS (India)
• Bain Medical (China)
• Farmasol (Italy)
• Tianjin Pharma (China)
• Hongda Medical (China)
• Baihe Medical (China)
• Far East Medical (Taiwan)
• Hemoclean (India)

INDUSTRIAL DEVELOPMENT

April 2023: Delta Med Group, a manufacturer of medical devices, has announced a partnership with DBM, a manufacturer of prefilled syringes. Delta Med Group and DBM will expand their product offerings by leveraging complementary products and R&D capabilities, enhancing their ability to serve customers. The partnership creates significant synergistic benefits and accelerates the growth path of the merged entity.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.